ASCVD Risk Estimator Plus

Tras la publicación de nueva guia 2013 de tto dislipemia es de gran utilidad

Should include bariatric surgery recommendations for patients that qualify. There are quite a few studies looking at CV risk reduction after surgery. The data should be included in this app. This app appears to ignore a major factor that plays a role (obesity) in about 35% (conservatively) of patients.

Not calculating, waste time

After all of the information is typed in, it is no longer calculating the current 10 yr risk percentage.

It said the age had to be between 40 and 71

Please update the app to reflect that aspirin is no longer indicated for primary prevention!

The app returns an estimated risk based on current data. However the Therapy impact suggests various scenarios that are imprudent. Start HBP meds when the patient doesn’t have HBP. Or intensify Statins for patients whose risk is less than 7.5%

This new version has some serious flaws. In addition to being harder to navigate than previous versions, it gives seriously incorrect values for ASCVD risk - last two patients I profiled both came back at 1.1% 10 year risk which is just not possible in the population I am seeing. Last person had a total cholesterol of 334! And still came back as 1.1% risk. Please scrap this version and go back to the old one.

I miss the old version which included more details on statins with high/moderate vs low intensity statins. A little harder to use now.

The estimation of therapy impact is useful and can be shown to patients so they understand rationale of treatment. The biggest fault is that fields requiring numerical data defaults to letter keyboard. It should automatically bring up the numerical keyboard to ease the burden of data entry.